On the other hand, TCF7L2 manifests an anti-tumor function by suppressing cell motility and invasiveness and by directly suppressing the activity of the pro-metastatic RUNX2–Runt-related transcription factor 2, its loss of function stimulating tumor malignancy [14,106,107]. The gene discussed is RUNX2; the disease is neoplasm.